ARCHIVES

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

This article is from The Cancer Letter archive.

Vol. 14 No. 37 | September 23, 1988

Download PDF Visit The Full Archive

Related Articles

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

May 5, 1995

AHCPR Invites Ideas for Outcomes Research

June 7, 1996